Financial Performance - The company's revenue for Q1 2025 was ¥315,662,234.29, representing a 43.52% increase compared to ¥219,942,064.63 in the same period last year[5]. - The net loss attributable to shareholders decreased to ¥12,756,486.98, a 72.01% improvement from a loss of ¥45,576,667.50 in the previous year[5]. - Basic and diluted earnings per share improved to ¥-0.0134, up 71.79% from ¥-0.0475 in the previous year[5]. - The company reported a net loss of ¥15,589,530.61, compared to a net loss of ¥44,286,323.71 in the previous period, indicating an improvement in financial performance[26]. - Total comprehensive income for the period was ¥-21,356,799.10, compared to ¥-57,137,857.45 in the previous period, showing a reduction in overall losses[26]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥-36,521,335.71, a significant decline of 675.75% compared to a positive cash flow of ¥6,343,271.16 in the same period last year[5]. - Operating cash flow generated a net outflow of ¥36,521,335.71, a significant decline from a net inflow of ¥6,343,271.16 in the previous period, highlighting cash flow challenges[28]. - The company's cash and cash equivalents decreased to CNY 257,153,760.78 from CNY 375,698,283.35, reflecting a decline of approximately 31.5%[20]. - The company's total liabilities increased, with cash and cash equivalents at the end of the period standing at ¥233,300,287.85, down from ¥314,720,829.76[28]. Assets and Liabilities - Total assets at the end of Q1 2025 were ¥3,945,983,317.97, a decrease of 1.82% from ¥4,019,170,670.70 at the end of the previous year[5]. - Total liabilities decreased to CNY 1,819,377,387.22 from CNY 1,875,453,209.03, indicating a decline of about 3.0%[22]. - The company's equity attributable to shareholders decreased to CNY 1,991,413,951.39 from CNY 2,006,889,890.10, reflecting a decrease of approximately 0.8%[22]. - The total operating costs for the current period amount to CNY 330,163,793.31, up from CNY 264,464,096.65 in the previous period, indicating an increase of about 24.8%[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 61,488[13]. - The largest shareholder, Ningbo Yaben Holdings Co., Ltd., holds 26.75% of shares, totaling 257,729,839 shares[13]. - The second-largest shareholder, Wang Xinya, holds 6.75% of shares, totaling 65,000,350 shares[13]. - The company has a total of 3,624,450 restricted shares at the end of the reporting period, with 906,113 shares added during the period[15]. - The company has signed a concerted action agreement among certain shareholders, maintaining relationships among some parties[14]. Research and Development - Research and development expenses increased by 51.96% to ¥29,449,161.26, up from ¥19,379,345.49 in the same period last year, indicating a focus on innovation[10]. - Research and development expenses increased to ¥29,449,161.26 from ¥19,379,345.49, reflecting a focus on innovation and new product development[25]. Financial Management - The company reported a significant increase in other income, which rose by 123.49% to ¥1,821,395.79, primarily due to government subsidies related to digital transformation[10]. - The company's financial expenses decreased by 86.98% to ¥1,344,753.10, largely due to the impact of exchange rate gains[10]. - The company incurred financial expenses of ¥1,344,753.10, a decrease from ¥10,328,357.64, indicating improved cost management[25]. - The company experienced a 34.42% increase in contract liabilities, reaching ¥11,308,308.10, primarily due to an increase in advance payments received[10]. Changes in Control and Governance - The actual controller of the company has changed, with the new controllers being Cai Tong and Wang Xinya, following the exit of Wang Zhuoying and Ma Lifan from the joint action agreement[18]. - The company continues to maintain its controlling shareholder, Ningbo Yaben Holdings Co., Ltd., despite the change in actual controllers[18]. - The company plans to hold a board election for the sixth board of directors, with terms lasting three years from the date of approval[17].
雅本化学(300261) - 2025 Q1 - 季度财报